Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

S&P Pharmaceuticals SPDR (XPH)

S&P Pharmaceuticals SPDR (XPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade XPH with:
  • Price/Earnings ttm 11.73
  • Annual Dividend & Yield 0.26 (0.56%)
  • Most Recent Dividend 0.089 on 09/20/21
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 17.93%
  • Historical Volatility 13.68%
  • IV Percentile 2%
  • IV Rank 6.59%
  • IV High 44.23% on 01/29/21
  • IV Low 16.07% on 06/18/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 5

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.12 +2.25%
on 09/20/21
50.42 -6.47%
on 08/24/21
-1.75 (-3.58%)
since 08/20/21
3-Month
46.12 +2.25%
on 09/20/21
53.82 -12.37%
on 07/29/21
-5.33 (-10.15%)
since 06/21/21
52-Week
42.22 +11.71%
on 09/24/20
56.32 -16.26%
on 02/16/21
+3.12 (+7.08%)
since 09/21/20

Most Recent Stories

More News
Pharma ETFs Gain on Q2 Earnings

Many industry bigwigs reported solid results with some beating on earnings or revenues or both.

PJP : 78.26 (+0.75%)
IHE : 185.37 (+0.18%)
XPH : 47.16 (+1.40%)
PPH : 73.02 (+0.52%)
FTXH : 25.62 (+0.58%)
Pharma ETFs in Focus Post Q1 Earnings

The slew of Q1 results have led to mixed trading in pharma ETFs over the past month.

PPH : 73.02 (+0.52%)
PJP : 78.26 (+0.75%)
IHE : 185.37 (+0.18%)
XPH : 47.16 (+1.40%)
FTXH : 25.62 (+0.58%)
Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

JNJ : 164.53 (+0.44%)
PFE : 43.92 (-0.63%)
MRK : 71.97 (+0.06%)
LLY : 230.17 (-0.63%)
BMY : 60.33 (-0.28%)
PPH : 73.02 (+0.52%)
PJP : 78.26 (+0.75%)
IHE : 185.37 (+0.18%)
XPH : 47.16 (+1.40%)
FTXH : 25.62 (+0.58%)
ETFs to Shine on Lilly's Coronavirus Antibody Progress

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 73.02 (+0.52%)
PJP : 78.26 (+0.75%)
IHE : 185.37 (+0.18%)
XPH : 47.16 (+1.40%)
3 Reasons to Bet on Healthcare ETFs

The broader medical sector should be in the spotlight now on hopes of a coronavirus vaccine and the likelihood of a divided congress.

AZN : 59.13 (+1.08%)
PFE : 43.92 (-0.63%)
GILD : 71.73 (+1.09%)
MRNA : 434.04 (+2.53%)
LLY : 230.17 (-0.63%)
PPH : 73.02 (+0.52%)
PJP : 78.26 (+0.75%)
XPH : 47.16 (+1.40%)
PSCH : 183.49 (+0.61%)
XHS : 107.20 (+0.37%)
FTXH : 25.62 (+0.58%)
Should You Invest in the SPDR SP Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 47.16 (+1.40%)
RPRX : 36.63 (-0.54%)
HZNP : 109.76 (+1.61%)
PJP : 78.26 (+0.75%)
IHE : 185.37 (+0.18%)
MYOK : 224.91 (+0.05%)
Q3 Earnings Fail to Impress Pharma ETFs

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

PPH : 73.02 (+0.52%)
PJP : 78.26 (+0.75%)
IHE : 185.37 (+0.18%)
XPH : 47.16 (+1.40%)
FTXH : 25.62 (+0.58%)
ETFs to Shine on Lilly's U.S. Deal for Coronavirus Antibody

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 73.02 (+0.52%)
PJP : 78.26 (+0.75%)
IHE : 185.37 (+0.18%)
XPH : 47.16 (+1.40%)
Healthcare ETFs Pop on Bristol Myers-MyoKardia Deal

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

BMY : 60.33 (-0.28%)
XBI : 130.25 (+1.16%)
XPH : 47.16 (+1.40%)
BBC : 47.39 (+1.43%)
SBIO : 47.03 (+1.68%)
MYOK : 224.91 (+0.05%)
ARKG : 81.30 (+1.21%)
Pharma ETFs to Benefit from Lilly's Coronavirus Antibody Progress

Lilly's progress in antibodies treatment is expected to raise investors optimism.

PPH : 73.02 (+0.52%)
PJP : 78.26 (+0.75%)
IHE : 185.37 (+0.18%)
XPH : 47.16 (+1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 47.80
2nd Resistance Point 47.53
1st Resistance Point 47.35
Last Price 47.16
1st Support Level 46.90
2nd Support Level 46.63
3rd Support Level 46.45

See More

52-Week High 56.32
Fibonacci 61.8% 50.93
Fibonacci 50% 49.27
Fibonacci 38.2% 47.60
Last Price 47.16
52-Week Low 42.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar